Loading insider details...
Beta
Latest Form 4 (Aug 4, 2026): Grant/Award of 7,500 JSPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 7,500 | n/a |
| Jun 13, 2026 | Pacira BioSciences, Inc. (PCRX) | Grant/Award | 32,675 | n/a |
| Sep 24, 2025 | Jasper Therapeutics, Inc. (JSPR) | Purchase | 41,000 | $99.6K |
| Jul 3, 2025 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 7,500 | n/a |
| Jun 9, 2025 | Annexon, Inc. (ANNX) | Grant/Award | 55,000 | n/a |
| Jun 10, 2024 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 7,500 | n/a |
| Jun 8, 2024 | Annexon, Inc. (ANNX) | Grant/Award | 44,000 | n/a |
| Mar 22, 2024 | CymaBay Therapeutics, Inc. (CBAY) | Disposition to Issuer | 80,000 | n/a |
| Jan 26, 2024 | CymaBay Therapeutics, Inc. (CBAY) | Grant/Award | 14,010 | n/a |
| Nov 30, 2023 | Jasper Therapeutics, Inc. (JSPR) | Purchase | 10,000 | $6.5K |